NDC 64764-300-20
Entyvio 300 mg/5mL
vedolizumab · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Entyvio is a injection, powder, lyophilized, for solution containing vedolizumab at a strength of 300 mg/5mL. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Entyvio
- Generic Name
- vedolizumab
- NDC Code (Package)
64764-300-20- NDC Code (Product)
64764-300- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 300 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125476
- Drug Class
- Integrin Receptor Antagonist [EPC]
- Marketing Start
- 05/20/2014
Recall History
No Recall HistoryView Full Drug Page
Entyvio — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.